Immune Systems Advisor

Before the COVID pandemic, Dr. Paul Marik became well-known for his development of a highly effective   sepsis protocol   using intravenous vitamin C, which resulted in a dramatic reduction in mortality rates. Then, in 2020, he cofounded the Front Line COVID-19 Critical Care Alliance (FLCCC) and subsequently published one of the most comprehensive and effective protocols for treating COVID-19. Despite a stellar career up to that point, the sin of insisting on early treatment for COVID-19, and sharing that information with the public, resulted in him being vilified, discredited and ultimately forced to resign. I'm a veteran of this too, so much so that the first two times I attempted to interview Marik, he turned down the invitation, in part because of how I was being portrayed by the media. "I was still digesting what was happening and I was unsure," Marik says. "I didn't realize how important you are in telling the truth and ...

The MATH+ Protocol Story January, 2020. Dr. Paul E. Marik, Professor of Medicine and Chief of the Division of Pulmonary and Critical Care Medicine at the Eastern Virginia Medical School in Norfolk, Virginia, creates a COVID-19 hospital treatment protocol for the medical school. Called the EVMS protocol, it is based on Dr. Marik’s safe, effective treatment protocol for sepsis — the famous “Marik Cocktail” of intravenous Hydrocortisone, Ascorbic Acid, and Thiamine (HAT). CITRIS-ALI, a large double-blind placebo controlled trial of high dose ascorbic acid (AA) in Acute Respiratory Distress Syndrome (ARDS) found that mortality decreased and ICU length-of-stay were markedly reduced in the treatment group. The reasons for the lack of immediate adoption of this therapy in ARDS can only be explained by the fact that the original primary outcome analysis failed to account for all the early excess deaths in the control group, where no Sequential Organ Failure Assessment (SOFA) score was assign...